Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells

類似資料

• The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling
  著者:: Valdez, Benigno C., 等
  出版事項: (2010)
• Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: enhancement of cytotoxicity with epigenetic modulators
  著者:: Valdez, Benigno C., 等
  出版事項: (2015)
• The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells
  著者:: Valdez, Benigno C., 等
  出版事項: (2017)
• Clofarabine±Fludarabine with Once Daily IV Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS
  著者:: Andersson, Borje S., 等
  出版事項: (2010)
• Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and SAHA in lymphoma cell lines
  著者:: Valdez, Benigno C., 等
  出版事項: (2011)